A liposome-hydrogel composite ameliorates UVB-induced mouse skin photoaging through integrated antioxidant and extracellular matrix remodeling pathways.
The study presents a liposome-hydrogel composite that may enhance the delivery of deer placenta polypeptides for skin protection against UVB-induced damage, but further research in humans is necessary.
Where it sits
this study against the rest of the matrixyl corpusSummary and findings
This study evaluated a liposome-hydrogel composite containing deer placenta polypeptides (DPP) for its effects on UVB-induced skin photoaging in mice. The composite formulation demonstrated a 2.7-fold enhancement in transdermal permeation. Topical administration resulted in marked alleviation of oxidative stress and extracellular matrix degradation.
Abstract
Skin photoaging, predominantly caused by chronic ultraviolet B (UVB) exposure, is characterized by oxidative stress, collagen degradation, and disruption of the skin barrier. Deer placenta polypeptides (DPP) are rich in bioactive amino acids (AAs); however, their antioxidant and dermo-protective effects remain insufficiently elucidated, and their topical application is limited by enzymatic instability and poor transdermal permeability. To overcome these limitations, we developed a liposome-hydrogel composite delivery system to enhance the stability, skin penetration, and bioactivity of DPP. DPP obtained <i>via</i> enzymatic hydrolysis exhibited a favorable AA profile, free radical-scavenging activity, and a low molecular weight distribution (3-14 kDa). DPP-loaded liposomes (DPP-LIP) demonstrated high encapsulation efficiency, uniform nanosize, and effective preservation of bioactivity. Incorporation of DPP-LIP into a sodium alginate (SA) hydrogel yielded a composite formulation (DPP-LIP-SA) with sustained-release properties and a 2.7-fold enhancement in transdermal permeation. In a UVB-induced photoaging mouse model, topical administration of DPP-LIP-SA markedly alleviated oxidative stress, inflammatory responses, DNA damage, and extracellular matrix degradation. Mechanistically, DPP-LIP-SA treatment activated the Nrf2/HO-1 antioxidant pathway, inhibited TLR4/MyD88/NF-κB-mediated inflammatory signaling, reduced reactive oxygen species accumulation and lipid peroxidation, and restored extracellular matrix homeostasis by promoting collagen synthesis while suppressing MMP-mediated collagen degradation. Collectively, these findings identify DPP as a potent bioactive peptide resource with intrinsic antioxidant and reparative properties and demonstrate that integration of nanocarriers with hydrogel matrices substantially enhances dermal bioavailability. This composite delivery platform shows strong potential as a peptide-based topical strategy for preventing and treating skin photoaging.
Background
The study addresses skin photoaging caused by UVB exposure, which leads to oxidative stress and collagen degradation. Previous research has indicated the potential of deer placenta polypeptides (DPP) as bioactive agents, but their clinical application has been limited due to stability and permeability issues. This study aims to explore a novel liposome-hydrogel composite delivery system to enhance the efficacy of DPP in mitigating photoaging effects.
Methods
The study utilized a UVB-induced photoaging mouse model to evaluate the effects of a DPP-loaded liposome-hydrogel composite (DPP-LIP-SA). The specific population, n, dose, and duration of treatment were not reported in abstract. Primary outcomes included measures of oxidative stress, inflammatory responses, and extracellular matrix integrity.
Results
Topical administration of DPP-LIP-SA resulted in a 2.7-fold enhancement in transdermal permeation. The treatment significantly alleviated oxidative stress, inflammatory responses, and DNA damage, though specific numeric values for these outcomes were not reported. Mechanistic studies indicated activation of the Nrf2/HO-1 pathway and inhibition of inflammatory signaling pathways.
Interpretation
The findings suggest that the DPP-LIP-SA composite may offer a promising approach for addressing skin photoaging, although the clinical significance of the observed effects remains uncertain. The study's reliance on a mouse model and lack of human data limit the applicability of results. Further research is needed to establish the efficacy and safety of this treatment in human subjects.
Key findings
- 2.7-fold enhancement in transdermal permeation of DPP-LIP-SA compared to controls.
- DPP-LIP-SA markedly alleviated oxidative stress, inflammatory responses, DNA damage, and extracellular matrix degradation.
- DPP obtained via enzymatic hydrolysis exhibited a low molecular weight distribution of 3-14 kDa.
Limitations
- Conducted in a mouse model, limiting human applicability.
- Duration of treatment and long-term effects not specified.
- Not reported in abstract.